Endo Int'l (ENDP) to Acquire Par Pharma in ~$8.05B Deal
Tweet Send to a Friend
Endo Int'l (Nasdaq: ENDP) and Par Pharmaceutical Holdings, Inc., announced that they have entered into a definitive agreement under which ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE